1WHO.Diagnosis and classification of diabetes mellitus and its complications 2 port of WHO consultation Part Ⅰ:Diagnosis and classification of diabetes mellitus.Geneva:WHO,1999:165-175.
6BRUM JF,ALOULOU I,VARLET-MARLE E.Hemirheological aspects of the metabolic syndrome:Markers of insulin resistance,obesity or hyperinsrlinemia.Clin Hemorheol Microcirc,2004,30(3-4):203-209.
7ALEXANDER CM,LANDSMAN PB,Teutsch SM,et al.NCEP-defined metabolic syndrom diabetes,and prevalence of coronary of coronary heart disease among NHANES Ⅲ participants age 50 years and older.Diabetes,2003,52(5):1 210.
8PYORALA M,MIETTINER H,HALONE P,et al.Insulin resistance syndrom redicts the risk of coronary heart disease and stroke in healthy middleaged men:The 22-year follow up results of the Helsinki Policemen Study.Arterioscler Thromb Vasc Biol,2000,20(2):538.
5Galipeau D, Verma S, McNeill JH. Female rats are protected against fructose-induced changes in metabolism and blood pressure. Am J Physiol Heart Circ Physiol, 2002,283: 2478-2484.
6Campbell SE, Febbraio MA. Effect of the ovarian hormones on GLUT4 expression and contraction-stimulated glucose uptake. Am J Physiol Endocrinol Metab,2002,282:1139-1146.
7Floter A, Nathorst-Boos J, Carlstrom K, et al. Serum lipids in oophorectomized women during estrogen and testosterone replacement therapy. Maturitas,2004,47:123-129.
8Brooks-Asplund EM, Shoukas AA, Kim SY, et al. Estrogen has opposing effects on vascular reactivity in obese, insulin-resistant male Zucker rats. J Appl Physiol, 2002,92: 2035-2044.
9Momoi H, Ikomi F, Ohhashi T. Estrogen-induced augmentation of endothelium-dependent nitric oxide-mediated vasodilation in isolated rat cerebral small arteries. Jpn J Physiol,2003,53:193-203.
10Borissova AM, Tankova T, Kamenova P, et al. Effect of hormone replacement therapy on insulin secretion and insulin sensitivity in postmenopausal diabetic women. Gynecol Endocrinol,2002,16:67-74.
